Technology · 1 sources covering this

Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer's

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 0 C · 1 R

How 1 sources are covering this

Economic TimesLean R·1h ago
Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development
Pathos AI said on Friday it had entered into a collaboration with Bristol Myers Squibb and Tempus AI to develop artificial intelligence tools for drug development in Alzheimer's
Read at Economic Times →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/75843522f02224b5bf80a366430a181e108adc74"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development"></iframe>

Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

How 1 sources are covering this

Pathos AI teams up with Bristol Myers and Tempus AI to advance drug development

More from Technology

[Weekly funding roundup Oct 17-23] VC funding falls below $100M amid lack of big deals

As chip prices surge, EV maker Ultraviolette is working on ways to absorb costs

Explained: Why is Meta creating a new class of non-voting shares amid its AI growth?

SK Hynix drops US IPO plan for Solidigm: Report

Reader

Trust & legal

Across the network